牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

昭衍新药（603127）

4.7

综合诊断：4.7分打败了32%的股票！

卖出
减持
中性
增持
买入

短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
中期趋势：
-
长期趋势：
已有139家主力机构披露2024-06-30报告期持股数据，持仓量总计6267.34万股，占流通A股9.94%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

3.5分

6.2分

5.5分

2.9分

5.1分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：3.5技术面打败了27%的股票技术面评分前10的股票

近期的平均成本为18.78元。

技术面得分最高的股票

平均成本

近期的平均成本为18.78元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"18.78","date":1732092041,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势接近大盘，接近行业平均水平。

[{"date":"2024.11.21","stock":"-0.16","trade":"-0.44","ind":"0.07"},{"date":"2024.11.20","stock":"4.02","trade":"2.72","ind":"0.66"},{"date":"2024.11.19","stock":"4.86","trade":"2.39","ind":"0.67"},{"date":"2024.11.18","stock":"-2.70","trade":"-3.50","ind":"-0.21"},{"date":"2024.11.15","stock":"-3.63","trade":"-3.11","ind":"-1.45"},{"date":"2024.11.14","stock":"-4.35","trade":"-3.97","ind":"-1.73"},{"date":"2024.11.13","stock":"-2.03","trade":"-1.49","ind":"0.51"},{"date":"2024.11.12","stock":"-0.61","trade":"1.61","ind":"-1.39"},{"date":"2024.11.11","stock":"1.59","trade":"2.97","ind":"0.51"},{"date":"2024.11.08","stock":"-0.51","trade":"0.47","ind":"-0.53"},{"date":"2024.11.07","stock":"2.35","trade":"2.80","ind":"2.57"},{"date":"2024.11.06","stock":"0.26","trade":"0.63","ind":"-0.09"},{"date":"2024.11.05","stock":"2.36","trade":"3.90","ind":"2.32"},{"date":"2024.11.04","stock":"10.02","trade":"2.62","ind":"1.17"},{"date":"2024.11.01","stock":"-3.25","trade":"-2.50","ind":"-0.24"},{"date":"2024.10.31","stock":"0.63","trade":"0.69","ind":"0.42"},{"date":"2024.10.30","stock":"-2.52","trade":"-2.07","ind":"-0.61"},{"date":"2024.10.29","stock":"-4.95","trade":"-2.51","ind":"-1.08"},{"date":"2024.10.28","stock":"3.87","trade":"2.57","ind":"0.68"},{"date":"2024.10.25","stock":"4.68","trade":"4.70","ind":"0.59"},{"date":"2024.10.24","stock":"-0.40","trade":"-0.70","ind":"-0.68"}]

昭衍新药,上证指数,医疗服务指数

压力支撑

该股压力位为18.75元，支撑位为18.45元。

[{"text":"\u538b\u529b\u4f4d","value":"18.75","date":1732118400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"18.45","date":1732118400,"color":"0x0b52a1"}]

多空趋势

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：6.2资金面打败了88%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力筹码很集中，呈高度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

医疗服务行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：11月21日 20:31

机构今日流向(万元)	-1048.65	机构5日流向(万元)	-5328.41
机构10日流向(万元)	-14991.37	机构20日流向(万元)	-8125.28

机构持仓

2024-06-30 与 2023-12-31 相比，主力机构持仓量减少1452.94万股，其中基金净增仓17家，主力净减仓34家，暂未发现中长期投资价值。

截止2024-06-30，共139家主力机构（基金137家，一般法人2家），持仓量总计6267.34万股，占流通A股9.94%
其中，基金持仓与2023-12-31相比：
增仓：54家，增持 487.87万股
减仓：37家，减持 251.42万股
新出现在主力名单中：25家，持有797.85万股
从主力名单中消失：59家，原持有2104.24万股

消息面诊股

诊断结果：5.5消息面打败了70%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	高管变动	因个人及工作原因	2024-10-30
一般消息	分红转增	不分配不转增	2024-08-31
一般消息	募资投向	公司购买资产	2024-08-31
一般消息	重大事项	关联交易	2024-08-31
利空	业绩预告	业绩预亏	2024-07-11
一般消息	股东大会	外资股类别股东大会	2024-05-29
一般消息	重大事项	关联交易	2024-05-10
利好	分红转增	10派1.6元(含税)	2024-03-29
利空	重大事项	公司违规：处罚类型	2024-02-09
一般消息	重大事项	关联交易	2024-02-06
重大利空	业绩预告	业绩大幅下降	2024-01-24
利好	重大事项	参股拟上市公司或非上市公司金融机构	2023-12-31

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	0条	2条
利空	3条	1条	2条

行业面诊股

诊断结果：2.9行业面打败了20%的股票医疗服务行业最新资金流向

近10日来该行业走势不明显，接近大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，接近大盘。

[{"date":"2024.11.21","price":"0.07","value":"-0.44"},{"date":"2024.11.20","price":"0.66","value":"2.72"},{"date":"2024.11.19","price":"0.67","value":"2.39"},{"date":"2024.11.18","price":"-0.21","value":"-3.50"},{"date":"2024.11.15","price":"-1.45","value":"-3.11"},{"date":"2024.11.14","price":"-1.73","value":"-3.97"},{"date":"2024.11.13","price":"0.51","value":"-1.49"},{"date":"2024.11.12","price":"-1.39","value":"1.61"},{"date":"2024.11.11","price":"0.51","value":"2.97"},{"date":"2024.11.08","price":"-0.53","value":"0.47"},{"date":"2024.11.07","price":"2.57","value":"2.80"},{"date":"2024.11.06","price":"-0.09","value":"0.63"},{"date":"2024.11.05","price":"2.32","value":"3.90"},{"date":"2024.11.04","price":"1.17","value":"2.62"},{"date":"2024.11.01","price":"-0.24","value":"-2.50"},{"date":"2024.10.31","price":"0.42","value":"0.69"},{"date":"2024.10.30","price":"-0.61","value":"-2.07"},{"date":"2024.10.29","price":"-1.08","value":"-2.51"},{"date":"2024.10.28","price":"0.68","value":"2.57"},{"date":"2024.10.25","price":"0.59","value":"4.70"},{"date":"2024.10.24","price":"-0.68","value":"-0.70"}]

上证指数,医疗服务行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	奥浦迈	33.94%	0.02%	5.3分
2	皓宸医疗	31.03%	-12.64%	5.3分
3	毕得医药	30.39%	3.93%	5.1分
4	美年健康	28.64%	4.70%	6.5分
5	普瑞眼科	20.99%	-10.26%	4.9分
6	创新医疗	18.19%	-9.24%	4.8分
7	凯莱英	16.36%	3.24%	5.5分
8	博腾股份	16.11%	-6.05%	3.5分
9	ST中珠	14.29%	-5.88%	4.7分
10	澳洋健康	13.59%	2.52%	5.6分
11	国际医学	12.08%	0.68%	6.0分
12	诺思格	11.26%	-2.23%	5.6分
13	益诺思	10.35%	-2.75%	4.7分
14	和元生物	10.34%	-4.95%	4.6分
15	南模生物	9.90%	-1.37%	4.2分
16	贝瑞基因	9.88%	3.38%	5.8分
17	海特生物	9.50%	-1.47%	4.9分
18	诺禾致源	9.18%	0.97%	5.4分
19	昭衍新药	8.96%	2.11%	4.7分
20	光正眼科	8.79%	-4.75%	5.1分
21	华康医疗	8.75%	1.09%	5.8分
22	新里程	8.66%	-2.13%	4.9分
23	三博脑科	8.15%	-8.55%	4.8分
24	皓元医药	6.64%	-7.50%	4.7分
25	诚达药业	6.15%	-8.92%	4.8分
26	药康生物	6.11%	0.15%	4.9分
27	南华生物	5.39%	1.09%	5.6分
28	何氏眼科	4.65%	-3.28%	4.4分
29	普蕊斯	4.55%	0.87%	6.0分
30	九洲药业	4.47%	0.45%	4.5分
31	爱尔眼科	4.24%	-3.72%	5.0分
32	药明康德	4.05%	-4.10%	4.6分
33	迪安诊断	3.92%	-1.63%	5.0分
34	华厦眼科	3.50%	-4.70%	4.8分
35	美迪西	3.15%	-1.61%	3.9分
36	博济医药	1.54%	-0.22%	5.3分
37	华大基因	1.32%	-2.20%	4.6分
38	阳光诺和	1.30%	-4.83%	5.2分
39	盈康生命	0.50%	-0.39%	5.7分
40	泓博医药	0.31%	-3.34%	5.2分
41	通策医疗	0.18%	-3.59%	4.6分
42	睿智医药	0.15%	-0.15%	5.0分
43	康龙化成	-0.18%	-3.60%	5.6分
44	万邦医药	-0.60%	-0.90%	5.5分
45	金凯生科	-0.65%	1.59%	5.3分
46	兰卫医学	-1.48%	2.01%	5.4分
47	诺泰生物	-1.69%	-0.92%	5.5分
48	成都先导	-2.24%	-8.12%	4.2分
49	药石科技	-2.47%	-3.73%	4.6分
50	泰格医药	-2.74%	0.12%	6.1分
51	百诚医药	-3.58%	-2.44%	5.6分
52	百花医药	-3.86%	-2.30%	4.5分
53	金域医学	-8.37%	-0.66%	5.0分
54	-	-	153.01%	分

<上一页 1 2 3 4 5...9 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：5.1基本面打败了19%的股票连续3年业绩增长30%的公司

该公司运营状况不佳，但多数机构认为该股有长期投资价值。

个股深一度

潜在高分红能力：中（87.5分）

基本面得分最高的股票

[ 截止日期：2024-09-30 ]公司经营

盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 40/96 ， 40/96。

[{"date":"2024-09-30","value":"-0.86","vol":"3.45"},{"date":"2024-06-30","value":"-2.10","vol":"2.65"},{"date":"2024-03-31","value":"-3.35","vol":"1.13"},{"date":"2023-12-31","value":"4.82","vol":"4.72"},{"date":"2023-09-30","value":"3.99","vol":"6.22"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
净资产收益率(%)	-0.86	-2.10	-3.35	4.82	3.99
行业(%)	3.45	2.65	1.13	4.72	6.22

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"27.48","vol":"36.79"},{"date":"2024-06-30","value":"30.37","vol":"36.95"},{"date":"2024-03-31","value":"32.84","vol":"36.12"},{"date":"2023-12-31","value":"42.62","vol":"39.51"},{"date":"2023-09-30","value":"43.77","vol":"40.64"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
销售毛利率(%)	27.48	30.37	32.84	42.62	43.77
行业(%)	36.79	36.95	36.12	39.51	40.64

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 49/96 ， 46/96。

[{"date":"2024-09-30","value":"-15.87","vol":"2.30"},{"date":"2024-06-30","value":"-16.08","vol":"2.66"},{"date":"2024-03-31","value":"-12.07","vol":"4.69"},{"date":"2023-12-31","value":"4.78","vol":"10.34"},{"date":"2023-09-30","value":"24.34","vol":"9.88"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
营业收入同比增长率(%)	-15.87	-16.08	-12.07	4.78	24.34
行业(%)	2.30	2.66	4.69	10.34	9.88

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"-121.46","vol":"-152.72"},{"date":"2024-06-30","value":"-287.30","vol":"-97.56"},{"date":"2024-03-31","value":"-244.98","vol":"-46.85"},{"date":"2023-12-31","value":"-63.04","vol":"0.01"},{"date":"2023-09-30","value":"-48.17","vol":"-386.50"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
净利润同比增长率(%)	-121.46	-287.30	-244.98	-63.04	-48.17
行业(%)	-152.72	-97.56	-46.85	0.01	-386.50

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 49/96 ， 52/96。

[{"date":"2024-09-30","value":"0.14","vol":"0.31"},{"date":"2024-06-30","value":"0.09","vol":"0.20"},{"date":"2024-03-31","value":"0.03","vol":"0.10"},{"date":"2023-12-31","value":"0.23","vol":"0.43"},{"date":"2023-09-30","value":"0.15","vol":"0.32"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
总资产周转率(次)	0.14	0.09	0.03	0.23	0.15
行业(次)	0.31	0.20	0.10	0.43	0.32

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"0.55","vol":"13.99"},{"date":"2024-06-30","value":"0.34","vol":"8.71"},{"date":"2024-03-31","value":"0.12","vol":"4.51"},{"date":"2023-12-31","value":"0.67","vol":"19.08"},{"date":"2023-09-30","value":"0.41","vol":"11.28"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
存货增长率(次)	0.55	0.34	0.12	0.67	0.41
行业(次)	13.99	8.71	4.51	19.08	11.28

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2024-09-30","value":"7.12","vol":"12.31"},{"date":"2024-06-30","value":"7.20","vol":"10.34"},{"date":"2024-03-31","value":"36.93","vol":"0.77"},{"date":"2023-12-31","value":"22.10","vol":"24.44"},{"date":"2023-09-30","value":"35.17","vol":"16.37"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
现金流量净额/营业收入	7.12	7.20	36.93	22.10	35.17
行业	12.31	10.34	0.77	24.44	16.37

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.79","vol":"1.47"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"1.33","vol":"2.51"},{"date":"2023-09-30","value":"","vol":"0.00"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
资本支出／折旧和摊销	-	1.79	-	1.33	-
行业	0.00	1.47	0.00	2.51	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 37/96 ， 33/96。

[{"date":"2024-09-30","value":"4.11","vol":"4.06"},{"date":"2024-06-30","value":"3.62","vol":"4.09"},{"date":"2024-03-31","value":"4.64","vol":"4.35"},{"date":"2023-12-31","value":"4.85","vol":"4.20"},{"date":"2023-09-30","value":"4.29","vol":"4.21"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
流动比率	4.11	3.62	4.64	4.85	4.29
行业	4.06	4.09	4.35	4.20	4.21

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"2.74","vol":"3.34"},{"date":"2024-06-30","value":"2.45","vol":"3.35"},{"date":"2024-03-31","value":"2.41","vol":"3.57"},{"date":"2023-12-31","value":"2.45","vol":"3.49"},{"date":"2023-09-30","value":"2.03","vol":"3.65"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
速动比率	2.74	2.45	2.41	2.45	2.03
行业	3.34	3.35	3.57	3.49	3.65

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 44/96 ， 43/96。

[{"date":"2024-09-30","value":"16.11","vol":"31.14"},{"date":"2024-06-30","value":"18.07","vol":"31.74"},{"date":"2024-03-31","value":"17.87","vol":"31.10"},{"date":"2023-12-31","value":"17.41","vol":"32.13"},{"date":"2023-09-30","value":"19.47","vol":"30.93"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
资产负债率(%)	16.11	18.07	17.87	17.41	19.47
行业(%)	31.14	31.74	31.10	32.13	30.93

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"0.19","vol":"0.84"},{"date":"2024-06-30","value":"0.22","vol":"0.86"},{"date":"2024-03-31","value":"0.22","vol":"0.91"},{"date":"2023-12-31","value":"0.21","vol":"1.05"},{"date":"2023-09-30","value":"0.24","vol":"1.70"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
产权比率 (%)	0.19	0.22	0.22	0.21	0.24
行业(%)	0.84	0.86	0.91	1.05	1.70

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
国泰君安	2024-11-03	买入
中信证券	2024-10-08	买入
国信证券	2024-09-13	买入

机构预测

机构预测该股2024年每股收益与前一年相同，长期投资价值一般。

[{"date":"2020","yellowRectValue":"3.15","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"5.57","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"10.74","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"3.97","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.79","blueLineValue":"0.11","type":"YC"}]

[昭衍新药]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]